(Circulation. 1996;94:718-726.)
© 1996 American Heart Association, Inc.
Articles |
1-Adrenergic Receptor Coupling With Gh in the Failing Human Heart
the Department of Molecular Cardiology and Center for Anesthesiology Research (W.E.S., C.S.M.), Research Institute, the Cleveland (Ohio) Clinic Foundation.
Correspondence to Mie-Jae Im, PhD, Department of Molecular Cardiology (FFB-37), Research Institute, the Cleveland Clinic Foundation, 9500 Euclid Ave, Cleveland, OH 44195.
Background We recently demonstrated that Gh, which transfers the signal from the
1-adrenergic receptor to the 69-kD phospholipase C, is the previously identified tissue-type transglutaminase (TGase II). The
1-adrenergic receptor mediates actions of the sympathetic nervous system, including cardiac, arteriolar, and smooth muscle contractions. In human cardiac tissue, the expression of the
1-adrenergic receptor is increased under pathophysiological conditions, but changes in the physiological response are small. Therefore, it has been suggested that the other components involved in the
1-adrenergic receptormediated signaling pathway are probably altered.
Methods and Results Immunological and biochemical studies with nonfailing and failing human heart tissues revealed that the GTP-binding and TGase activities of human heart TGase II (hhG
h) are downregulated in both ischemic and dilated cardiomyopathic human heart. In ischemic cardiomyopathy, the
1-adrenergic receptor number increased twofold (27.0 fmol/mg) compared with the nonfailing (12.8 fmol/mg) and the dilated cardiomyopathic (15.6 fmol/mg) heart tissues, but the coupling of hhG
h with the
1-adrenergic receptor did not increase. The intrinsic activity of hhG
h was greatly decreased in membrane fractions, whereas the cytosolic TGase activity was not changed. In the dilated cardiomyopathic human heart, these intrinsic enzyme activities of hhG
h were also downregulated in the membrane fraction, whereas the amount of hhG
h protein was greatly increased (2.8-fold) compared with the nonfailing heart.
Conclusions The results of the present study clearly demonstrate that the
1-adrenergic receptor in human heart couples with Gh (TGase II) and indicate that downregulation of hhG
h activity is associated with human cardiac failure but that the mechanism differs between ischemic and dilated cardiomyopathies.
Key Words: heart failure receptors, adrenergic, alpha transglutaminase II proteins signal transduction
This article has been cited by other articles:
![]() |
K. Y. Chae, J.-H. Kim, W.-J. Park, Y.-G. Kim, H.-Y. Yun, N. S. Kwon, M.-J. Im, and K. J. Baek Distinct pH Modulation for Dual Function of G{alpha}h (Transglutaminase II) J. Biochem., March 1, 2005; 137(3): 407 - 413. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. K. Kang, K. S. Yi, N. S. Kwon, K.-H. Park, U.-H. Kim, K. J. Baek, and M.-J. Im {alpha}1B-Adrenoceptor Signaling and Cell Motility: GTPase FUNCTION OF Gh/TRANSGLUTAMINASE 2 INHIBITS CELL MIGRATION THROUGH INTERACTION WITH CYTOPLASMIC TAIL OF INTEGRIN {alpha} SUBUNITS J. Biol. Chem., August 27, 2004; 279(35): 36593 - 36600. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. E. Iismaa and R. M. Graham Dissecting Cardiac Hypertrophy and Signaling Pathways: Evidence for an Interaction Between Multifunctional G Proteins and Prostanoids Circ. Res., May 30, 2003; 92(10): 1059 - 1061. [Full Text] [PDF] |
||||
![]() |
Z. Zhang, R. Vezza, T. Plappert, P. McNamara, J. A. Lawson, S. Austin, D. Pratico, M. S.-J. Sutton, and G. A. FitzGerald COX-2-Dependent Cardiac Failure in Gh/tTG Transgenic Mice Circ. Res., May 30, 2003; 92(10): 1153 - 1161. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Ziegelhoffer, P. S Tappia, N. Mesaeli, N. Sahi, N. S Dhalla, and V. Panagia Low level of sarcolemmal phosphatidylinositol 4,5-bisphosphate in cardiomyopathic hamster (UM-X7.1) heart Cardiovasc Res, January 1, 2001; 49(1): 118 - 126. [Abstract] [Full Text] [PDF] |
||||
![]() |
O.-E. Brodde and M. C. Michel Adrenergic and Muscarinic Receptors in the Human Heart Pharmacol. Rev., December 1, 1999; 51(4): 651 - 690. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Small, J.-F. Feng, J. Lorenz, E. T. Donnelly, A. Yu, M.-J. Im, G. W. Dorn II, and S. B. Liggett Cardiac Specific Overexpression of Transglutaminase II (Gh) Results in a Unique Hypertrophy Phenotype Independent of Phospholipase C Activation J. Biol. Chem., July 23, 1999; 274(30): 21291 - 21296. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. S. Tappia, S.-Y. Liu, S. Shatadal, N. Takeda, N. S. Dhalla, and V. Panagia Changes in sarcolemmal PLC isoenzymes in postinfarct congestive heart failure: partial correction by imidapril Am J Physiol Heart Circ Physiol, July 1, 1999; 277(1): H40 - H49. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. McDonough, D. K. Arrell, and J. E. Van Eyk Troponin I Degradation and Covalent Complex Formation Accompanies Myocardial Ischemia/Reperfusion Injury Circ. Res., January 22, 1999; 84(1): 9 - 20. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Zhang, M. Lesort, R. P. Guttmann, and G. V. W. Johnson Modulation of the in Situ Activity of Tissue Transglutaminase by Calcium and GTP J. Biol. Chem., January 23, 1998; 273(4): 2288 - 2295. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. L. Stiles Multifunctional G Proteins: Searching for Functions in the Heart Circulation, August 15, 1996; 94(4): 602 - 603. [Full Text] |
||||
![]() |
N. Nanda, S. E. Iismaa, W. A. Owens, A. Husain, F. Mackay, and R. M. Graham Targeted Inactivation of Gh/Tissue Transglutaminase II J. Biol. Chem., June 1, 2001; 276(23): 20673 - 20678. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1996 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |